The inventive b-Safe Products are presently undergoing regulatory approval through the CE and the FDA for Distribution in the US and EU. We hope to also obtain approval for other markets in time.
We are compiling design data now and will be releasing full specifications for the b-Safe Products Protocol soon.
Please contact us for more information on our release schedule and how you may help lower the effects of infectious transfers.
Check out the introduction video for our b-SAFE PROTOCOL.